The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Targeting inflammation to treat diabetic kidney disease: the road to 2030
Abstract
Diabetic kidney disease (DKD) is one of the fastest growing causes of chronic kidney disease and associated morbidity and mortality. Preclinical research has demonstrated the involvement of inflammation in its pathogenesis and in the progression of kidney damage, supporting clinical trials designed to explore anti-inflammatory strategies. However, the recent success of sodium-glucose cotransporter-2 inhibitors and the nonsteroidal mineralocorticoid receptor antagonist finerenone has changed both guidelines and standard of care, rendering obsolete older studies directly targeting inflammatory mediators and the clinical development was discontinued for most anti-inflammatory drugs undergoing clinical trials for DKD in 2016. Given the contribution of inflammation to the pathogenesis of DKD, we review the impact on kidney inflammation of the current standard of care, therapies undergoing clinical trials or repositioned drugs for DKD. Moreover, we review recent advances in the molecular regulation of inflammation in DKD and discuss potential novel therapeutic strategies with clinical relevance. Finally, we provide a roadmap for future research aimed at integrating the growing knowledge on inflammation and DKD into clinical practice to foster improvement of patient outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032183 · Cited by 5,205
Tirzepatide Once Weekly for the Treatment of Obesity
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206038 · Cited by 3,838
Macrophage activation and polarization
Martinez, F. O. (2008) · Frontiers in Bioscience · doi:10.2741/2692 · Cited by 3,160
Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes
Bakris, G. L., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Rossing, P., Kolkhof, P., Nowack, C., Schloemer, P., Joseph, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2025845 · Cited by 2,935
Ahlqvist, E., Storm, P., Käräjämäki, A., Martinell, M., Dorkhan, M., Carlsson, A., Vikman, P., Prasad, R. B., Aly, D. M., Almgren, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30051-2 · Cited by 2,335
Cardiovascular events with finerenone in kidney disease and type 2 diabetes
Pitt, B., Filippatos, G., Agarwal, R., Anker, S. D., Bakris, G. L., Rossing, P., Joseph, A., Kolkhof, P., Nowack, C., Schloemer, P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2110956 · Cited by 1,814
Kristensen, S. L., Rørth, R., Jhund, P. S., Docherty, K. F., Sattar, N., Preiss, D., Køber, L., Petrie, M. C., & McMurray, J. J. V. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30249-9 · Cited by 1,663
The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway
Baird, L., & Yamamoto, M. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00099-20 · Cited by 1,542
Hickson, L. J., Langhi Prata, L. G. P., Bobart, S. A., Evans, T. K., Giorgadze, N., Hashmi, S. K., Herrmann, S. M., Jensen, M. D., Jia, Q., Jordan, K. L., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.069 · Cited by 1,383
Agarwal, R., Filippatos, G., Pitt, B., Anker, S. D., Rossing, P., Joseph, A., Kolkhof, P., Nowack, C., Gebel, M., Ruilope, L. M., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab777 · Cited by 1,317
Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases
Shi, Y., Wang, Y., Li, Q., Liu, K., Hou, J., Shao, C., & Wang, Y. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0023-5 · Cited by 1,223
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
de Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G. L., Chin, M., Christ-Schmidt, H., Goldsberry, A., Houser, M., Krauth, M., Lambers Heerspink, H. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306033 · Cited by 1,030
Targeting the progression of chronic kidney disease
Ruiz-Ortega, M., Rayego-Mateos, S., Lamas, S., Ortiz, A., & Rodrigues-Diez, R. R. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0248-y · Cited by 979
Self-citationThe Role of Inflammatory Cytokines in Diabetic Nephropathy
Navarro-González, J. F., & Mora-Fernández, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091048 · Cited by 932
Self-citationBardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pergola, P. E., Raskin, P., Toto, R. D., Meyer, C. J., Huff, J. W., Grossman, E. B., Krauth, M., Ruiz, S., Audhya, P., Christ-Schmidt, H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105351 · Cited by 890
Ruiz, S., Pergola, P. E., Zager, R. A., & Vaziri, N. D. (2013) · Kidney International · doi:10.1038/ki.2012.439 · Cited by 718
Inflammation, Immunity, and Hypertensive End-Organ Damage
McMaster, W. G., Kirabo, A., Madhur, M. S., & Harrison, D. G. (2015) · Circulation Research · doi:10.1161/circresaha.116.303697 · Cited by 708
Metabolically healthy obesity: facts and fantasies
Smith, G. I., Mittendorfer, B., & Klein, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129186 · Cited by 645
Transcriptome Analysis of Human Diabetic Kidney Disease
Woroniecka, K. I., Park, A. S. D., Mohtat, D., Thomas, D. B., Pullman, J. M., & Susztak, K. (2011) · Diabetes · doi:10.2337/db10-1181 · Cited by 642
Vallon, V., & Thomson, S. C. (2017) · Diabetologia · doi:10.1007/s00125-016-4157-3 · Cited by 635
Heerspink, H. J. L., Parving, H.-H., Andress, D. L., Bakris, G., Correa-Rotter, R., Hou, F.-F., Kitzman, D. W., Kohan, D., Makino, H., McMurray, J. J. V., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30772-x · Cited by 628
Sanz, A. B., Sanchez-Niño, M. D., Ramos, A. M., Moreno, J. A., Santamaria, B., Ruiz-Ortega, M., Egido, J., & Ortiz, A. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020218 · Cited by 567
Self-citationThe single-cell transcriptomic landscape of early human diabetic nephropathy
Wilson, P. C., Wu, H., Kirita, Y., Uchimura, K., Ledru, N., Rennke, H. G., Welling, P. A., Waikar, S. S., & Humphreys, B. D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908706116 · Cited by 539
Syn, N. L., Cummings, D. E., Wang, L. Z., Lin, D. J., Zhao, J. J., Loh, M., Koh, Z. J., Chew, C. A., Loo, Y. E., Tai, B. C., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00591-2 · Cited by 521
Avosentan for Overt Diabetic Nephropathy
Mann, J. F. E., Green, D., Jamerson, K., Ruilope, L. M., Kuranoff, S. J., Littke, T., & Viberti, G. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060593 · Cited by 492
Drug repositioning: a brief overview
Jourdan, J.-P., Bureau, R., Rochais, C., & Dallemagne, P. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13273 · Cited by 470
Heerspink, H. J. L., Perco, P., Mulder, S., Leierer, J., Hansen, M. K., Heinzel, A., & Mayer, G. (2019) · Diabetologia · doi:10.1007/s00125-019-4859-4 · Cited by 457
Niewczas, M. A., Pavkov, M. E., Skupien, J., Smiles, A., Md Dom, Z. I., Wilson, J. M., Park, J., Nair, V., Schlafly, A., Saulnier, P.-J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0415-5 · Cited by 432
Lin, B., Koibuchi, N., Hasegawa, Y., Sueta, D., Toyama, K., Uekawa, K., Ma, M., Nakagawa, T., Kusaka, H., & Kim-Mitsuyama, S. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0148-1 · Cited by 423
Tesch, G. H. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00016.2008 · Cited by 417
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
Wagner, R., Heni, M., Tabák, A. G., Machann, J., Schick, F., Randrianarisoa, E., Hrabě de Angelis, M., Birkenfeld, A. L., Stefan, N., Peter, A., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-1116-9 · Cited by 415
Activators and inhibitors of NRF2: a review of their potential for clinical development
Robledinos-Antón, N., Fernández-Ginés, R., Manda, G., & Cuadrado, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9372182 · Cited by 413
Kodera, R., Shikata, K., Kataoka, H. U., Takatsuka, T., Miyamoto, S., Sasaki, M., Kajitani, N., Nishishita, S., Sarai, K., Hirota, D., et al. (2011) · Diabetologia · doi:10.1007/s00125-010-2028-x · Cited by 394
The Inflammatory Cytokines TWEAK and TNFα Reduce Renal Klotho Expression through NFκB
Moreno, J. A., Izquierdo, M. C., Sanchez-Niño, M. D., Suárez-Alvarez, B., Lopez-Larrea, C., Jakubowski, A., Blanco, J., Ramirez, R., Selgas, R., Ruiz-Ortega, M., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010101073 · Cited by 388
Self-citationNF- B activation and overexpression of regulated genes in human diabetic nephropathy
Mezzano, S., Aros, C., Droguett, A., Burgos, M. E., Ardiles, L., Flores, C., Schneider, H., Ruiz-Ortega, M., & Egido, J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh207 · Cited by 381
Self-citationVallon, V., Rose, M., Gerasimova, M., Satriano, J., Platt, K. A., Koepsell, H., Cunard, R., Sharma, K., Thomson, S. C., & Rieg, T. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00409.2012 · Cited by 370
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
Opazo-Ríos, L., Mas, S., Marín-Royo, G., Mezzano, S., Gómez-Guerrero, C., Moreno, J. A., & Egido, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072632 · Cited by 363
11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s011 · Cited by 344
Terami, N., Ogawa, D., Tachibana, H., Hatanaka, T., Wada, J., Nakatsuka, A., Eguchi, J., Horiguchi, C. S., Nishii, N., Yamada, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100777 · Cited by 341
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
Rayego-Mateos, S., Morgado-Pascual, J. L., Opazo-Ríos, L., Guerrero-Hue, M., García-Caballero, C., Vázquez-Carballo, C., Mas, S., Sanz, A. B., Herencia, C., Mezzano, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113798 · Cited by 334
Self-citationXiang, E., Han, B., Zhang, Q., Rao, W., Wang, Z., Chang, C., Zhang, Y., Tu, C., Li, C., & Wu, D. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01852-y · Cited by 331
Ridker, P. M., MacFadyen, J. G., Glynn, R. J., Koenig, W., Libby, P., Everett, B. M., Lefkowitz, M., Thuren, T., & Cornel, J. H. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.490 · Cited by 297
Endothelin: 30 Years From Discovery to Therapy
Barton, M., & Yanagisawa, M. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12105 · Cited by 295
Grune, J., Beyhoff, N., Smeir, E., Chudek, R., Blumrich, A., Ban, Z., Brix, S., Betz, I. R., Schupp, M., Foryst-Ludwig, A., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10360 · Cited by 292
de Zeeuw, D., Bekker, P., Henkel, E., Hasslacher, C., Gouni-Berthold, I., Mehling, H., Potarca, A., Tesar, V., Heerspink, H. J. L., & Schall, T. J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00261-2 · Cited by 273
Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers
Dekkers, C. C. J., Petrykiv, S., Laverman, G. D., Cherney, D. Z., Gansevoort, R. T., & Heerspink, H. J. L. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13301 · Cited by 263
Nagaishi, K., Mizue, Y., Chikenji, T., Otani, M., Nakano, M., Konari, N., & Fujimiya, M. (2016) · Scientific Reports · doi:10.1038/srep34842 · Cited by 257
Chow, F. Y., Nikolic-Paterson, D. J., Ma, F. Y., Ozols, E., Rollins, B. J., & Tesch, G. H. (2007) · Diabetologia · doi:10.1007/s00125-006-0497-8 · Cited by 250
Macrophage Phenotype and Fibrosis in Diabetic Nephropathy
Calle, P., & Hotter, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082806 · Cited by 249
Li, J., Liu, H., Takagi, S., Nitta, K., Kitada, M., Srivastava, S. P., Takagaki, Y., Kanasaki, K., & Koya, D. (2020) · JCI Insight · doi:10.1172/jci.insight.129034 · Cited by 245
Necroinflammation in Kidney Disease
Mulay, S. R., Linkermann, A., & Anders, H.-J. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015040405 · Cited by 231
Navarro-González, J. F., Mora-Fernández, C., Muros de Fuentes, M., Chahin, J., Méndez, M. L., Gallego, E., Macía, M., del Castillo, N., Rivero, A., Getino, M. A., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010012 · Cited by 221
Self-citationShimazaki, A., Kawamura, Y., Kanazawa, A., Sekine, A., Saito, S., Tsunoda, T., Koya, D., Babazono, T., Tanaka, Y., Matsuda, M., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1171 · Cited by 214
Modelling diabetic nephropathy in mice
Azushima, K., Gurley, S. B., & Coffman, T. M. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.142 · Cited by 209
Menne, J., Eulberg, D., Beyer, D., Baumann, M., Saudek, F., Valkusz, Z., Więcek, A., Haller, H., & for the Emapticap Study Group (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv459 · Cited by 201
Oxidative Stress and Inflammation in Renal and Cardiovascular Complications of Diabetes
Charlton, A., Garzarella, J., Jandeleit-Dahm, K. A. M., & Jha, J. C. (2020) · Biology · doi:10.3390/biology10010018 · Cited by 200
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes
van Zuydam, N. R., Ahlqvist, E., Sandholm, N., Deshmukh, H., Rayner, N. W., Abdalla, M., Ladenvall, C., Ziemek, D., Fauman, E., Robertson, N. R., et al. (2018) · Diabetes · doi:10.2337/db17-0914 · Cited by 195
Endothelin A Receptor Blockade Reduces Diabetic Renal Injury via an Anti-Inflammatory Mechanism
Sasser, J. M., Sullivan, J. C., Hobbs, J. L., Yamamoto, T., Pollock, D. M., Carmines, P. K., & Pollock, J. S. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006030208 · Cited by 193
The Signaling of Cellular Senescence in Diabetic Nephropathy
Xiong, Y., & Zhou, L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7495629 · Cited by 185
Barrera-Chimal, J., Estrela, G. R., Lechner, S. M., Giraud, S., El Moghrabi, S., Kaaki, S., Kolkhof, P., Hauet, T., & Jaisser, F. (2018) · Kidney International · doi:10.1016/j.kint.2017.12.016 · Cited by 183
Biomarkers of inflammation and repair in kidney disease progression
Puthumana, J., Thiessen-Philbrook, H., Xu, L., Coca, S. G., Garg, A. X., Himmelfarb, J., Bhatraju, P. K., Ikizler, T. A., Siew, E. D., Ware, L. B., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci139927 · Cited by 182
Packer, M. (2020) · Circulation: Heart Failure · doi:10.1161/circheartfailure.120.007197 · Cited by 176
Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes
Nair, A. T. N., Wesolowska‐Andersen, A., Brorsson, C., Rajendrakumar, A. L., Hapca, S. M., Gan, S., Dawed, A. Y., Donnelly, L. A., McCrimmon, R. J., Doney, A. S. F., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01790-7 · Cited by 176
Therapeutic approaches to diabetic nephropathy—beyond the RAS
Fernandez-Fernandez, B., Ortiz, A., Gomez-Guerrero, C., & Egido, J. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.74 · Cited by 170
Self-citationTargeting inflammation in diabetic nephropathy: a tale of hope
Moreno, J. A., Gomez-Guerrero, C., Mas, S., Sanz, A. B., Lorenzo, O., Ruiz-Ortega, M., Opazo, L., Mezzano, S., & Egido, J. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1538352 · Cited by 170
Self-citationYu, S., Cheng, Y., Zhang, L., Yin, Y., Xue, J., Li, B., Gong, Z., Gao, J., & Mu, Y. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1474-8 · Cited by 168
Rossing, P. R., Filippatos, G. S., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Chan, J. C. N., Kooy, A., McCafferty, K., Schernthaner, G., et al. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.10.008 · Cited by 167
Abdollahi, E., Keyhanfar, F., Delbandi, A., Falak, R., Hajimiresmaiel, S. J., & Shafiei, M. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174715 · Cited by 167
Iannantuoni, F., M. de Marañon, A., Diaz-Morales, N., Falcon, R., Bañuls, C., Abad-Jimenez, Z., Victor, V. M., Hernandez-Mijares, A., & Rovira-Llopis, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111814 · Cited by 166
Navaneethan, S. D., Zoungas, S., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Liew, A., Michos, E. D., Olowu, W. A., Sadusky, T., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m20-5938 · Cited by 163
Xu, C., Wang, W., Zhong, J., Lei, F., Xu, N., Zhang, Y., & Xie, W. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.013 · Cited by 161
DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease
Smyth, L. J., McKay, G. J., Maxwell, A. P., & McKnight, A. J. (2014) · Epigenetics · doi:10.4161/epi.27161 · Cited by 160
Ketogenesis impact on liver metabolism revealed by proteomics of lysine β-hydroxybutyrylation
Koronowski, K. B., Greco, C. M., Huang, H., Kim, J., Fribourgh, J. L., Crosby, P., Mathur, L., Ren, X., Partch, C. L., Jang, C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109487 · Cited by 151
Wilson, J. M., Lin, Y., Luo, M. J., Considine, G., Cox, A. L., Bowsman, L. M., Robins, D. A., Haupt, A., Duffin, K. L., & Ruotolo, G. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14553 · Cited by 149
Disease-dependent mechanisms of albuminuria
Comper, W. D., Hilliard, L. M., Nikolic‐Paterson, D. J., & Russo, L. M. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00142.2008 · Cited by 149
Sattarinezhad, A., Roozbeh, J., Yeganeh, B. S., Omrani, G. R., & Shams, M. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.05.010 · Cited by 148
Navarro‐González, J. F., Fernández, C. M., Rivero, A., Gallego, E., Chahin, J., Macia, M. L., Méndez, M. L., & García, J. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70182-4 · Cited by 143
Self-citationRICORS2040: the need for collaborative research in chronic kidney disease
Ortíz, A., Roger, M., Jimenez, V. M., Jr., Pérez, J. C. R., Furlano, M. M., Atxer, L. S., Zurro, D. G., Casabona, C. M. R., Zurro, D. G., Gómez, C. G., et al. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab170 · Cited by 142
Self-citationInflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
Donate-Correa, J., Ferri, C. M., Sánchez-Quintana, F., Pérez-Castro, A., González-Luis, A., Martín-Núñez, E., Mora-Fernández, C., & Navarro-González, J. F. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.628289 · Cited by 140
Self-citationIncreased renal cellular senescence in murine high-fat diet: effect of the senolytic drug quercetin
Kim, S. R., Jiang, K., Ogrodnik, M., Chen, X., Zhu, X.-Y., Lohmeier, H., Ahmed, L., Tang, H., Tchkonia, T., Hickson, L. J., et al. (2019) · Translational Research · doi:10.1016/j.trsl.2019.07.005 · Cited by 139
Klotho, phosphate and inflammation/ageing in chronic kidney disease
Izquierdo, M. C., Pérez-Gómez, M. V., Sánchez-Niño, M. D., Sanz, A. B., Ruiz‐Andrés, O., Poveda, J., Moreno, J. A., Egido, J., & Ortíz, A. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs426 · Cited by 138
EMT and proteinuria as progression factors
Strutz, F. M. (2008) · Kidney International · doi:10.1038/ki.2008.425 · Cited by 138
Carlsson, L. M. S., Sjöholm, K., Karlsson, C., Jacobson, P., Andersson‐Assarsson, J. C., Svensson, P., Larsson, I., Hjorth, S., Neovius, M., Taube, M., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30061-x · Cited by 138
Protective Role of Nrf2 in Renal Disease
Guerrero‐Hue, M., Rayego‐Mateos, S., Vázquez‐Carballo, C., Palomino‐Antolín, A., García‐Caballero, C., Opazo-Ríos, L., Morgado‐Pascual, J. L., Herencia, C., Mas, S., Ortíz, A., et al. (2020) · Antioxidants · doi:10.3390/antiox10010039 · Cited by 138
Self-citationThe ERA Registry Annual Report 2019: summary and age comparisons
Boenink, R., Astley, M. E., Huijben, J. A., Stel, V. S., Kerschbaum, J., Ots-Rosenberg, M., Åsberg, A., Lopot, F., Golan, E., de la Nuez, P. C., et al. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab273 · Cited by 137
Tsujikawa, L. M., Fu, L., Das, S., Halliday, C., Rakai, B. D., Stotz, S. C., Sarsons, C. D., Gilham, D., Daze, E., Wasiak, S., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0696-z · Cited by 134
Nangaku, M., Kanda, H., Takama, H., Ichikawa, T., Hase, H., & Akizawa, T. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.03.030 · Cited by 133
Uromodulin Triggers IL-1β–Dependent Innate Immunity via the NLRP3 Inflammasome
Darisipudi, M. N., Thomasová, D., Mulay, S. R., Brech, D., Noeßner, E., Liapis, H., & Anders, H. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012040338 · Cited by 132
Role of Macrophages and Related Cytokines in Kidney Disease
Cantero‐Navarro, E., Rayego‐Mateos, S., Orejudo, M., Tejedor-Santamaria, L., Tejera‐Muñoz, A., Sanz, A. B., Márquez‐Expósito, L., Marchant, V. A., Santos‐Sanchez, L., Egido, J., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.688060 · Cited by 129
Self-citationImmunology of the ageing kidney
Sato, Y., & Yanagita, M. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0185-9 · Cited by 126
Stasch, J., Schlossmann, J., & Hocher, B. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.12.014 · Cited by 124
Navarro‐González, J. F., Mora, C., Muros, M., & Garcı́a, J. G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010001 · Cited by 121
Self-citationSGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia
Fernández‐Fernández, B., Sarafidis, P. A., Kanbay, M., Navarro‐González, J. F., Soler, M. J., Górriz, J. L., & Ortíz, A. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa198 · Cited by 120
Self-citationKim, M. N., Moon, J. H., & Cho, Y. M. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14503 · Cited by 120
Ishibashi, Y., Matsui, T., & Yamagishi, S. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1555791 · Cited by 119
Lavoz, C., Matus, Y. S., Orejudo, M., Carpio, J. D., Droguett, A., Egido, J., Mezzano, S. A., & Ruiz‐Ortega, M. (2019) · Kidney International · doi:10.1016/j.kint.2018.12.031 · Cited by 116
Self-citationBlockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice
Seok, S. J., Lee, E., Kim, G. T., Hyun, M., Lee, J.-H., Chen, S., Choi, R., Kim, H. M., Lee, E. Y., & Chung, C. H. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs555 · Cited by 113
Antifibrotic Agents for the Management of CKD: A Review
Ruiz‐Ortega, M., Lamas, S., & Ortíz, A. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.11.010 · Cited by 113
Self-citationSystematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease
Sheng, X., Qiu, C., Liu, H., Gluck, C. A., Hsu, J. Y., He, J., Hsu, C., Sha, D., Weir, M. R., Isakova, T., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005905117 · Cited by 108
Albumin downregulates Klotho in tubular cells
Fernández‐Fernández, B., Izquierdo, M. C., Rivas, L. V., Nastou, D., Sanz, A. B., Ortíz, A., & Sánchez-Niño, M. D. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx376 · Cited by 107
Fontecha‐Barriuso, M., Martín‐Sánchez, D., Martinez-Moreno, J. M., Carrasco, S., Ruiz‐Andrés, O., Monsalve, M., Sánchez‐Ramos, C., Gómez, M. J., Ruiz‐Ortega, M., Sánchez-Niño, M. D., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5282 · Cited by 105
Self-citationBromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases
Morgado‐Pascual, J. L., Rayego‐Mateos, S., Tejedor-Santamaria, L., Suárez-Álvarez, B., & Ruiz‐Ortega, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01315 · Cited by 103
Self-citationMolecular Mechanisms of Kidney Injury and Repair
Rayego‐Mateos, S., Márquez‐Expósito, L., Rodrigues‐Díez, R., Sanz, A. B., Guiteras, R., Doladé, N. G., Rubio-Soto, I., Manonelles, A., Codina, S., Ortíz, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031542 · Cited by 103
Self-citationTan, S. M., Ziemann, M., Thallas‐Bonke, V., Snelson, M., Kumar, V., Laskowski, A., Nguyen, T.-V., Huynh, K., Clarke, M. V., Libianto, R., et al. (2019) · Diabetes · doi:10.2337/db19-0043 · Cited by 99
Effects of Selonsertib in Patients with Diabetic Kidney Disease
Chertow, G. M., Pérgola, P. E., Fang, C., Kirby, B. J., Sundy, J. S., Patel, U. D., & for the GS-US-223-1015 Investigators (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018121231 · Cited by 97
ADDENDA-BHS2 trial investigators, Sposito, A. C., Breder, I. S. S., Soares, A., Kimura-Medorima, S. T., Munhoz, D., Cintra, R. M. R., Bonilha, I., de Oliveira, D. C., Breder, J. D. S. C., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01264-z · Cited by 95
Bardoxolone methyl: drug development for diabetic kidney disease
Kanda, H., & Yamawaki, K. (2020) · Clinical and Experimental Nephrology · doi:10.1007/s10157-020-01917-5 · Cited by 93
Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls
Aranda‐Rivera, A. K., Cruz‐Gregorio, A., Pedraza‐Chaverrí, J., & Scholze, A. (2022) · Antioxidants · doi:10.3390/antiox11061112 · Cited by 93
Tumor necrosis factor-α as a therapeutic target for diabetic nephropathy
Navarro‐González, J. F., Jarque, A., Muros, M., Fernández, C. M., & Garcı́a, J. G. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.02.005 · Cited by 89
Self-citationDoke, T., Huang, S., Qiu, C., Liu, H., Guan, Y., Hu, H., Ma, Z., Wu, J., Miao, Z., Sheng, X., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci141801 · Cited by 87
Targeting inflammation in diabetic kidney disease: early clinical trials
Pérez-Gómez, M. V., Sánchez-Niño, M. D., Sanz, A. B., Zheng-Lin, B., Martín-Cleary, C., Ruiz‐Ortega, M., Ortíz, A., & Fernández‐Fernández, B. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1196184 · Cited by 84
Self-citationNavarro‐González, J. F., Sánchez-Niño, M. D., Donate‐Correa, J., Martín‐Núñez, E., Ferri, C. M., Pérez‐Delgado, N., Górriz, J. L., Martínez‐Castelao, A., Ortíz, A., & Fernández, C. M. (2018) · Diabetes Care · doi:10.2337/dc18-0078 · Cited by 79
Self-citationXu, Y., Gao, H., Hu, Y., Fang, Y., Qi, C., Huang, J., Cai, X., Wu, H., Ding, X., & Zhang, Z. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.06.008 · Cited by 76
Abbas, N. A. T., Salem, A. E., & Awad, M. M. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1544-y · Cited by 75
Functional methylome analysis of human diabetic kidney disease
Park, J., Guan, Y., Sheng, X., Gluck, C. A., Seasock, M. J., Hakimi, A. A., Qiu, C., Pullman, J. M., Verma, A. K., Li, H., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128886 · Cited by 74
Pérez-Gómez, M. V., Sánchez-Niño, M. D., Sanz, A. B., Martín-Cleary, C., Ruiz‐Ortega, M., Egido, J., Navarro‐González, J. F., Ortíz, A., & Fernández‐Fernández, B. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4061325 · Cited by 72
Self-citationLin, S., Chen, Y., Chiang, W., Wu, K., & Tsai, T. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.05.012 · Cited by 72
Suárez-Álvarez, B., Morgado‐Pascual, J. L., Rayego‐Mateos, S., Rodríguez, R. M. A., Rodrigues-Díez, R. R., Cannata‐Ortiz, P., Sanz, A. B., Egido, J., Tharaux, P., Ortíz, A., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015080910 · Cited by 72
Self-citationSancar-Bas, S., Gezginci-Oktayoglu, S., & Bolkent, S. (2015) · Growth Factors · doi:10.3109/08977194.2015.1125349 · Cited by 71
Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
Martinez-Moreno, J. M., Fontecha‐Barriuso, M., Martín‐Sánchez, D., Guerrero‐Mauvecin, J., Gomá-Garcés, E., Fernández‐Fernández, B., Carriazo, S. M., Sánchez-Niño, M. D., Ramos, A. M., Ruiz‐Ortega, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114113 · Cited by 71
Self-citationRaverdy, V., COHEN, R. V., Caiazzo, R. J., Verkindt, H., Petry, T. B. Z., Marciniak, C., Legendre, B. L., Bauvin, P., Chatelain, E., Duhamel, A., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00005-5 · Cited by 71
Role of the adaptive immune system in diabetic kidney disease
Kong, L., Andrikopoulos, S., MacIsaac, R. J., Mackay, L. K., Nikolic‐Paterson, D. J., Torkamani, N., Zafari, N., Marin, E. C. S., & Ekinci, E. I. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13725 · Cited by 70
Serum interleukin-6 levels predict kidney disease progression in diabetic nephropathy
Álamo, B. S., Shabaka, A., Cachofeiro, V., Cases‐Corona, C., & Juarez, G. M. F. (2021) · Clinical Nephrology · doi:10.5414/cn110223 · Cited by 67
Ortíz, A., Ferro, C. J., Balafa, O. C., Burnier, M., Ekart, R., Halimi, J., Kreutz, R. H., Mark, P. B., Persu, A., Rossignol, P., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab167 · Cited by 66
Kalantar‐Zadeh, K., Schwartz, G. G., Nicholls, S. J., Buhr, K. A., Ginsberg, H. N., Johansson, J. O., Kulikowski, E., Lebioda, K. E., Toth, P. P., Wong, N. C. W., et al. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.16751020 · Cited by 64
Tobin, J. V., Zimmer, D. P., Shea, C. M., Germano, P., Bernier, S. G., Liu, G., Long, K., Miyashiro, J. S., Ranganath, S. H., Jacobson, S., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.247429 · Cited by 63
ELMO1 increases expression of extracellular matrix proteins and inhibits cell adhesion to ECMs
Shimazaki, A., Tanaka, Y., Shinosaki, T., Ikeda, M., Watada, H., Hirose, T., Kawamori, R., & Maeda, S. (2006) · Kidney International · doi:10.1038/sj.ki.5001939 · Cited by 62
Glucagon-Like Peptide 1 and Its Cleavage Products Are Renoprotective in Murine Diabetic Nephropathy
Moellmann, J., Klinkhammer, B. M., Onstein, J., Stöhr, R., Jankowski, V., Jankowski, J., Lebherz, C., Tacke, F., Marx, N., Boor, P., et al. (2018) · Diabetes · doi:10.2337/db17-1212 · Cited by 60
Kim, H., Lee, C., Cha, H., Choe, J., Park, E., & Kim, J. (2014) · Rheumatology International · doi:10.1007/s00296-014-3146-4 · Cited by 58
Huang, C.-C., Chou, C., Chen, W., Yang, J., Lee, W., Chen, J., Lee, C., & Li, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212408 · Cited by 58
Boustany, C., Harrison, P. C., Chen, H., Lincoln, K. A., Qian, H. S., Clifford, H., Wang, H., Zhang, X., Gueneva-Boucheva, K., Bosanac, T., et al. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.230706 · Cited by 57
The Complement Pathway: New Insights into Immunometabolic Signaling in Diabetic Kidney Disease
Tan, S. M., Snelson, M., Østergaard, J. A., & Coughlan, M. T. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0125 · Cited by 55
Tziastoudi, M., Stefanidis, I., Hadjigeorgiou, G. M., STRAVODIMOS, K. G., & Zintzaras, E. (2017) · Clinical Kidney Journal · doi:10.1093/ckj/sfx008 · Cited by 54
Hickson, L. J., Abedalqader, T., Ben-Bernard, G., Mondy, J., Bian, X., Conley, S. M., Zhu, X., Herrmann, S. M., Kukla, A., Lorenz, E. C., et al. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0419 · Cited by 53
Mitogen-Activated Protein Kinase 14 Promotes AKI
Ortíz, A., Husi, H., González‐Lafuente, L., Rivas, L. V., Fresno, M., Sanz, A. B., Mullen, W., Albalat, A., Mezzano, S. A., Vlahou, T., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015080898 · Cited by 52
Gale, J. D., Gilbert, S. A., Blumenthal, S. S., Elliott, T., Pérgola, P. E., Goteti, K., Scheele, W. H., & Huguet, C. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.07.010 · Cited by 52
Acute Kidney Injury is Aggravated in Aged Mice by the Exacerbation of Proinflammatory Processes
Márquez‐Expósito, L., Tejedor-Santamaria, L., Santos‐Sanchez, L., Valentijn, F. A., Cantero‐Navarro, E., Rayego‐Mateos, S., Rodrigues-Díez, R. R., Tejera‐Muñoz, A., Marchant, V. A., Sanz, A. B., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.662020 · Cited by 52
Self-citationCould IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?
Lavoz, C., Rayego‐Mateos, S., Orejudo, M., Opazo-Ríos, L., Marchant, V. A., Márquez‐Expósito, L., Tejera‐Muñoz, A., Navarro‐González, J. F., Droguett, A., Ortíz, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010272 · Cited by 51
Self-citationArandjelovic, S., Perry, J. S. A., Lucas, C. D., Penberthy, K. K., Kim, T., Zhou, M., Rosen, D. A., Chuang, T.-Y., Bettina, A. M., Shankman, L. S., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0293-x · Cited by 48
Hanrahan, J. P., de Boer, I. H., Bakris, G. L., Wilson, P. J., WAKEFIELD, J. D., Seferović, J. P., Chickering, J. G., Chien, Y., Carlson, K. E., Cressman, M. D., et al. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08410520 · Cited by 45
Sarafidis, P. A., Ortíz, A., Ferro, C. J., Halimi, J., Kreutz, R. H., Mallamaci, F., Mancia, G., & Wanner, C. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002776 · Cited by 45
Fernández, C. M., Sánchez-Niño, M. D., Donate‐Correa, J., Martín‐Núñez, E., Pérez‐Delgado, N., Rivas, L. V., Fernández‐Fernández, B., Ortíz, A., & Navarro‐González, J. F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113677 · Cited by 45
Self-citationLerma, E. V., & Wilson, D. J. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2094770 · Cited by 42
DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity
Cao, A., Li, J., Asadi, M., Basgen, J. M., Zhu, B., Yi, Z., Jiang, S., Doke, T., Shamy, O. E., Patel, N., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci141279 · Cited by 41
Atrasentan for the treatment of diabetic nephropathy
Egido, J., Rojas-Rivera, J. E., Mas, S., Ruiz‐Ortega, M., Sanz, A. B., Parra, E. G., & Gómez‐Guerrero, C. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1325872 · Cited by 40
Self-citationChang, J.-T., Liang, Y., Hsu, C., Chen, C., Chen, P., Yang, Y.-F., Chen, Y., Pei, D., Chang, J., & Leu, J. (2017) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-017-0172-3 · Cited by 39
Role of Senescent Renal Cells in Pathophysiology of Diabetic Kidney Disease
Wiley, C. D. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01314-y · Cited by 39
Winkler, T. W., Rasheed, H., Teumer, A., Gorski, M., Rowan, B. X., Stanzick, K. J., Thomas, L. F., Tin, A., Hoppmann, A., Chu, A. Y., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03448-z · Cited by 39
Urine proteomics identifies biomarkers for diabetic kidney disease at different stages
Fan, G., Gong, T., Lin, Y., Wang, J., Sun, L., Wei, H., Yang, X., Liu, Z., Li, X., Zhao, L., et al. (2021) · Clinical Proteomics · doi:10.1186/s12014-021-09338-6 · Cited by 38
Eickhoff, M. K., Olsen, F. J., Frimodt‐Møller, M., Díaz, L. J., Faber, J. O., Jensen, M. T., Rossing, P. R., & Persson, F. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107590 · Cited by 37
Benardeau, A. M., Kahnert, A., Schomber, T., Meyer, J., Pavkovic, M., Kretschmer, A., Lawrenz, B., Hartmann, E., Mathar, I., Hueser, J., et al. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02149-4 · Cited by 35
Su, Y., Wang, Y., Liu, M., & Chen, H. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12157 · Cited by 34
Development of Biomarkers and Molecular Therapy Based on Inflammatory Genes in Diabetic Nephropathy
Maiti, A. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189985 · Cited by 33
Complement factor B in high glucose–induced podocyte injury and diabetic kidney disease
Lu, Q., Hou, Q., Cao, K., Sun, X., Liang, Y., Gu, M., Xue, X., Zhao, A. Z., & Dai, C. (2021) · JCI Insight · doi:10.1172/jci.insight.147716 · Cited by 33
Hohenstein, B., Daniel, C., Wagner, A., Stasch, J., & Hugo, C. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00280.2004 · Cited by 32
Empagliflozin Inhibits IL-1β-Mediated Inflammatory Response in Human Proximal Tubular Cells
Pirklbauer, M., Sallaberger, S., Staudinger, P., Corazza, U., Leierer, J., Mayer, G. J., & Schramek, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105089 · Cited by 32
Ferroptosis and kidney disease
Martín‐Sánchez, D., Fontecha‐Barriuso, M., Martinez-Moreno, J. M., Ramos, A. M., Sánchez-Niño, M. D., Guerrero‐Hue, M., Moreno, J. A., Ortíz, A., & Sanz, A. B. (2020) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2020.09.006 · Cited by 31
Valentijn, F. A., Knoppert, S. N., Márquez‐Expósito, L., Rodrigues-Díez, R. R., Pissas, G., Tang, J., Tejedor-Santamaria, L., Broekhuizen, R., Samarakoon, R., Eleftheriadis, T., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.030 · Cited by 30
Self-citationSarafidis, P. A., Ferro, C. J., Morales, E., Ortíz, A., Małyszko, J., Hojs, R., Khazim, K., Ekart, R., Valdivielso, J. M., Fouque, D. P., et al. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz137 · Cited by 27
Osonoi, T., Gouda, M., Kubo, M., Arakawa, K., Hashimoto, T., & Abe, M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0169 · Cited by 26
Extracellular Vesicles as Theranostic Tools in Kidney Disease
Huang, W., Zhu, X.-Y., Lerman, A., & Lerman, L. O. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.16751221 · Cited by 24
Zhang, L., Li, W., Gong, M., Zhang, Z., Xue, X., Mao, J., Zhang, H., Li, S., Liu, X., Wu, F., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202200198r · Cited by 22
Mechanistic insights into glucose induced vascular epigenetic reprogramming in type 2 diabetes
Dhawan, P., Vasishta, S., Balakrishnan, A., & Joshi, M. B. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120490 · Cited by 21
Role of ELMO1 in inflammation and cancer—clinical implications
Tocci, S., Ibeawuchi, S., Das, S., & Sayed, I. M. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00680-x · Cited by 20
Donate‐Correa, J., Sánchez-Niño, M. D., González-Luis, A., Ferri, C. M., Martín-Olivera, A., Martín‐Núñez, E., Fernández‐Fernández, B., Tagua, V. G., Fernández, C. M., Ortíz, A., et al. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac143 · Cited by 19
Self-citationTargeting Inflammation in Diabetic Kidney Disease: Is There a Role for Pentoxifylline?
Leehey, D. J. (2020) · Kidney360 · doi:10.34067/kid.0001252019 · Cited by 18
SGLT2 inhibitors and finerenone: one or the other or both?
Neuen, B. L., & Jardine, M. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac046 · Cited by 16
Li, M., Sun, Z., Chang, D., Yu, X., Wang, S., Chen, M., & Zhao, M. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13264 · Cited by 16
Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice
Opazo-Ríos, L., Tejera‐Muñoz, A., Soto‐Catalán, M., Marchant, V. A., Lavoz, C., Mas, S., Moreno, J. A., Fierro‐Fernández, M., Ramos, R., Suárez-Álvarez, B., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.778776 · Cited by 15
Self-citationBădilă, E. (2020) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2020.487 · Cited by 14
Lu, W., Ren, S., Dong, W., Li, X., Zheng, Z., Jia, Y., & Xue, Y. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022055 · Cited by 11
ASK1 Inhibitor in Chronic Kidney Disease Therapy: From Bench to Bedside
Wen, L., & Wei, Q. (2022) · Kidney360 · doi:10.34067/kid.0002562022 · Cited by 6
Cited by
González, P., Lozano, P., Ros, G., & Solano, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119352 · Cited by 777
Combination therapy for kidney disease in people with diabetes mellitus
van Raalte, D. H., Bjornstad, P., Cherney, D. Z. I., de Boer, I. H., Fioretto, P., Gordin, D., Persson, F., Rosas, S. E., Rossing, P., Schaub, J. A., et al. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00827-z · Cited by 127
Diabetes and its complications: molecular mechanisms, prevention and treatment
Zhao, L., Yuan, J., Yang, Q., Ma, J., Yang, F., Zou, Y., Liu, K., & Liu, F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02401-w · Cited by 80
Metadata
- Authors
- Rayego-Mateos, S., Rodrigues-Diez, R. R., Fernandez-Fernandez, B., Mora-Fernández, C., Marchant, V., Donate-Correa, J., Navarro-González, J. F., Ortiz, A., & Ruiz-Ortega, M.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2023-02
- Volume
- 103
- Issue
- 2
- Pages
- 282-296
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W4312141101
- Cited by
- 366
- References
- 172
- FWCI
- 35.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.